Mitochondrial DNA mutations in human neoplasia

Journal of Applied Genetics

Volumn 47, Issue 1, 2006, Pages 67-78

  Czarnecka, Anna M ^a,b   Golik, Paweł ^a,c   Bartnik, Ewa ^a,c  

^a UNIVERSITY OF WARSAW   (Poland)

^b POSTGRADUATE SCHOOL OF MOLECULAR MEDICINE   (Poland)

^c INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

Author keywords

Cancer; Mitochondria; MtDNA; Mutation

Indexed keywords

MUS MUSCULUS;

EID: 32544443022     PISSN: 12341983     EISSN: 12341983     Source Type: Journal    
DOI: 10.1007/BF03194602     Document Type: Review

References (92)

1. Abu-Amero KK, Alzahrani AS, Zou M, Shi Y, 2005. High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines. Oncogene 24: 1455-1460.
2. Alazzouzi H, Farriol M, Espin E, Armengol M, Pena M, Zeh K, et al. 2003. Molecular patterns of nuclear and mitochondrial microsatellite alterations in breast tumors. Oncol Rep 10: 1561-1567.
3. Alonso A, Martin P, Albarran C, Aquilera B, Garcia O, Guzman A, et al. 1997. Detection of somatic mutations in the mitochondrial DNA control region of colorectal and gastric tumors by heteroduplex and single-strand conformation analysis. Electrophoresis 18: 682-685.
4. Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, et al. 1981. Sequence and organization of the human mitochondrial genome. Nature 290: 457-465.
5. Augenlicht LH, Heerdt BG, 2001. Mitochondria: integrators in tumorigenesis? Nature Genetics 28: 104-105.
6. Bartnik E, Lorenc A, Mroczek K, 2001. Human mitochondria in health, disease, ageing and cancer. J Appl Genet 42: 65-71.
7. Benda J, 1994. Pathology of cervical carcinoma and its prognostic implications. Semin Oncol 21: 3-11.
8. Berkan M, 2003. Nowotwory nabłmkowe skóry [Epithelial skin neoplasms]. In: Kordek R, Jassem J, Krzakowski M, Jeziorski A, eds., Onkologia. Podrȩcznik dla studentów i lekarzy [Oncology: Handbook for students and physicians]. Medical Press, Gdańsk.
9. Bianchi MS, Bianchi NO, Bailliet G, 1995. Mitochondrial DNA mutations in normal and tumor tissues from breast cancer patients. Cytogenet Cell Genet 71: 99-103.
10. Bianchi NO, Bianchi MS, Richard SM, 2001. Mitochondrial genome instability in human cancer. Rev Mutat Res 488: 9-23.
11. Brener A, Piekarski J, 2003. Rak jelita grubego [Colon cancer]. In: Kordek R, Jassem J, Krzakowski M, Jeziorski A, eds., Onkologia. Podrȩcznik dla studentów i lekarzy [Oncology: Handbook for students and physicians]. Medical Press, Gdańsk.
12. Burgart LJ, Zheng J, Shu Q, Strickler JG, Shibata D, 1995. Somatic mitochondrial mutation in gastric cancer. Am J Pathol 147: 1105-1111.
13. Capuano F, Guerrieri F, Papa S, 1997. Oxidative phosphorylation enzymes in normal and neoplastic cell growth. J Bioenerg 29: 379-384.
14. Castle PE, Wacholder S, Lorincz AT, Scott DR, Sherman ME, Glass AG, et al. 2002. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst 94: 1406-1414.
15. Chen JZ, Kadlubar FF, 2004. Mitochondrial mutagenesis and oxidative stress in human prostate cancer. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 22: 1-12.
16. Chester KA, Robson L, Begent RH, Pringle H, Primrose L, Talbot IC, et al. 1990. In situ and slot hybridization analysis of RNA in colorectal tumours and normal colon shows distinct distributions of mitochondrial sequences. J Pathol 162: 309-315.
17. Clevers H, 2004. At the crossroads of inflammation and cancer. Cell 118: 671-674.
18. Debniak T, Gorski B, Huzarski T, Byrski T, Cybulski C, Mackiewicz A, et al. 2005. A common variant of CDKN2A (p16) predisposes to breast cancer. J Med Genet 42: 763-765.
19. Deichmann M, Kahle B, Benner A, Thome M, Helmke B, Naher H, 2004. Somatic mitochondrial mutations in melanoma resection specimens. Int J Oncol 24: 137-141.
20. Desagher S, Martinou JC, 2000. Mitochondria as the central control point of apoptosis. TRENDS in Cell Biology 10: 396-377.
21. Durham SE, Krishnan KJ, Betts J, Birch-Machin MA, 2003. Mitochondrial DNA damage in non-melanoma skin cancer. Br J Cancer 88: 90-95.
22. Fearon ER, Vogelstein B, 1990. A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
23. Fernandez-Silva P, Enriquez JA, Montoya J, 2003. Replication and transcription of mammalian mitochondrial DNA. Exp Physiol 88: 41-56.
24. Fine G, Chan K, 1985. Alimentary tract. In: Damjanov L, Linder J, eds., Anderson's Pathology. Vol. 2. C.V. Mosby, Saint Louis 2: 1055-1095.
25. Gleason DF, 1966. Classification of prostate carcinomas. Cancer. Chemother Rep 50: 125-128.
26. Gleason DF, Mellinger GT, 1974. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 111: 58-64.
27. Gorski B, Cybulski C, Huzarski T, Byrski T, Gronwald J, Jakubowska A, et al. 2005. Breast cancer predisposing alleles in Poland. Breast Cancer Res Treat 92: 19-24.
28. Habano W, Nakamura S, Sugai T, 1998. Microsatellite instability in the mitochondrial DNA of colorectal carcinomas: evidence for mismatch repair systems in mitochondrial genome. Oncogene 17: 1931-1937.
29. Habano W, Sugai T, Yoshida T, Nakamura S, 1999. Mitochondrial gene mutation, but not large-scale deletion, is a feature of colorectal carcinomas with mitochondrial microsatellite instability. Int J Cancer 83: 625-629.
30. Hood DA, Adhihetty PJ, Colavecchia M, Gordon JW, Irrcher I, Joseph AM, et al. 2003. Mitochondrial biogenesis and the role of the protein import path-way. Med Sei Sport & Exercise 35: 86-94.
31. Huzarski T, Lener M, Domagala W, Gronwald J, Byrski T, Kurzawski G, et al. 2005. The 3020insC allele of NOD2 predisposes to early-onset breast cancer. Breast Cancer Res Treat 89: 91-93.
32. Isaacs C, Cavalli LR, Cohen Y, Pennanen M, Shankar LK, Freedman M, et al. 2004. Detection of LOH and mitochondrial DNA alterations in ductal lavage and nipple aspirate fluids from hngh-risk patients. Breast Cancer Res Treat 84: 99-105.
33. Jackson MJ, Papa S, Bolanos J, Bruckdorfer R, Carlsen H, Elliott RM, et al. 2002. Antioxidants, reactive oxygen and nitrogen species, gene induction and mitochondrial function. Mol Aspects Med 23: 209-285.
34. Jeronimo C, Nomoto S, Caballero OL, Usadel H, Henrique R, Varzim G, et al. 2001. Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene 20: 5195-5198.
35. Jeziorski A, 2003. Rak piersi [Breaswt cancer]. In: Kordek R, Jassem J, Krzakowski M, Jeziorski A, eds., Onkologia. Podrȩcznik dla studentów i lekarzy [Oncology: Handbook for students and physicians]. Medical Press, Gdańsk.
36. Kirkinezos IG, Moraes CT, 2001. Reactive oxygen species and mitochondrial diseases. Semin Cell Dev Biol 12: 449-457.
37. Kozakiewicz B, 2003. Nowotwory złośliwe narza̧du rodnego [Malignancies of female reproductive organs]. Nowa Medycyna - Onkologia VI 3.
38. Krishnan KJ, Harbottle A, Birch-Machin MA, 2004. The use of a 3895 bp mitochondrial DNA deletion as a marker for sunlight exposure in human skin. J Invest Dermatol 123: 1020-1024.
39. Krus S, Skrzypek-Fakhoury E, 1996. Patomorfologia kliniczna [Clinical pathomorphology]. PZWL, Warszawa.
40. Kubiak R, Bieńkiewicz A, 2003. Rak szyjki macicy [Cervical cancer]. In: Kordek R, Jassem J, Krzakowski M, Jeziorski A, eds., Onkologia. Podrȩcznik dla studentów i lekarzy [Oncology: Handbook for students and physicians]. Medical Press, Gdańsk.
41. Lee HC, Yin PH, Lin JC, Wu CC, Chen CY, Wu CW, et al. 2005. Mitochondrial genome instability and mtDNA depletion in human cancers. Ann N Y Acad Sci 1042: 109-122.
42. Lenaz G, Baracca A, Carelli V, D'Aurelio M, Sgarbi G, Solaini G, 2004. Bioenergetics of mitochondrial diseases associated with mtDNA mutations. Biochim Biophys Acta 1658: 89-94.
43. Li HX, Zhong S, Li CH, 2003. Study on the mitochondrion DNA mutation in tumor tissues of gynecologic oncology patients. Zhonghua Fu Chan Ke Za Zhi 38: 290-293.
44. Li TT, Zhao LN, Liu ZG, Han Y, Fan DM, 2005. Regulation of apoptosis by the papillomavirus E6 oncogene. World J Gastroenterol 11: 931-937.
45. Lievre A, Chapusot C, Bouvier AM, Zinzindohoue F, Piard F, Roignot P, et al. 2005. Clinical value of mitochondrial mutations in colorectal cancer. J Clin Oncol 23: 3517-3525.
46. Liu VW, Shi HH, Cheung AN, Chiu PM, Leung TW, Nagley P, et al. 2001. High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res 61: 5998-6001.
47. Liu Y, Fiskum G, Schubert D, 2002. Generation of reactive oxygen species by the mitochondrial electron transport chain. J Neurochem 80: 780-787.
48. Longworth MS, Laimins LA, 2004. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 68: 362-372.
49. Lorenc A, Bryk J, Golik P, Kupryjańczyk J, Ostrowski J, Pronicki M, et al. 2003. Homoplasmic MELAS A3243G mtDNA mutation in colon cancer sample. Mitochondrion 3: 119-124.
50. Lu X, Walker T, MacManus JP, Seligy VL, 1992. Differentiation of HT-29 human colonic adenocarcinoma cells correlates with increased expression of mitochondrial RNA: effects of trehalose on cell growth and maturation. Cancer Res 52: 3718-3725.
51. Lubinski J, Phelan CM, Ghadirian P, Lynch HT, Garber J, Weber B, et al. 2004. Cancer variation associated with the position of the mutation in the BRCA2 gene. Fam Cancer 3: 1-10.
52. Mathupala SP, Rempel A, Pedersen PL, 1997. Aberrant glycolytic metabolism of cancer cells: A remarkable coordination of genetic, transcriptional, posttranslational, and mutational events that lead to a criticsal role for type II heksokinase. J Bioenerg Biomemb 29: 339-343.
53. Mattiazzi M, D'Aurelio M, Gajewski CD, Martushova K, Kiaei M, Beal MF, et al. 2002. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J Biol Chem 277: 29626-29633.
54. Mattiazzi M, Vijayvergiya C, Gajewski CD, DeVivo DC, Lenaz G, Wiedmann M, 2004. The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by antioxidants. Hum Mol Genet 13: 869-879.
55. Maximo V, Scares P, Lima J, Cameselle-Teijeiro J, Sobrinho-Simoes M, 2002. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroidpathology: A study with emphasis on hürthle cell tumors. Am J Pathol 160: 1857-1865.
56. Maximo V, Soares P, Seruca R, Rocha AS, Castro P, Sobrinho-Simoes M, 2001. Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma. Genes Chromosomes Cancer 32: 136-143.
57. Modica-Napolitano JS, Singh K, 2002. Mitochondria as targets for detection and treatment of cancer. Expert Rev Mol Med 2002: 1-19.
58. Morson B, 1974. President's address. The polyp-cancer sequence in the large bowel. Proc R Soc Med 67: 451-457.
59. Nejc D, 2003. Czerniak [Melanoma]. In: Kordek R, Jassem J, Krzakowski M, Jeziorski A, eds., Onkologia. Podrȩcznik dla studentów i lekarzy [Oncology: Handbook for students and physicians]. Medical Press, Gdańsk.
60. Nomoto S, Yamashita K, Koshikawa K, Nakao A, Sidransky D, 2002. Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma. Clin Cancer Res 8:481-487.
61. Okochi O, Hibi K, Uemura T, Inoue S, Takeda S, Kaneko T, Nakao A, 2002. Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients. Clin Cancer Res 8:2875-2878.
62. Parrella P, Seripa D, Matera MG, Rabitti C, Rinaldi M, Mazzarelli P, et al. 2003. Mutations of the D310 mitochondrial mononucleotide repeat in primary tumors and cytological specimens. Cancer Lett 190: 73-77.
63. Parrella P, Xiao Y, Fliss M, Sanchez-Cespedes M, Mazzarelli P, Rinaldi M, et al. 2001. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res 61: 7623-7626.
64. Pejovic T, Ladner D, Intengan M, Zheng K, Fairchild T, Dillon D, et al. 2004. Somatic D-loop mitochondrial DNA mutations are frequent in uterine serous carcinoma. Eur J Cancer 40:2519-2524.
65. Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, et al. 2005. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 102: 719-724.
66. Piekarski J, Brener A, 2003. Pierwotne nowotwory wa̧troby [Primary liver neoplasms]. In: Kordek R, Jassem J, Krzakowski M, Jeziorski A, eds., Onkologia. Podrȩcznik dla studentów i lekarzy [Oncology: Handbook for students and physicians]. Medical Press, Gdańsk.
67. Polyak K, Li Y, Zhu H, Lengauer C, Willson JK, Markowitz SD, et al. 1998. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet 20: 291-293.
68. Pomara G, Cappello F, 2003. RE: heat shock proteins: their role in urological tumors - Letters to the Editor. J Urol 170: 927-929.
69. Pomorski L, Kordek R, Kubiak R, 2003. Nowotwory tarczycy [Thyroid neoplasms]. In: Kordek R, Jassem J, Krzakowski M, Jeziorski A, eds., Onkologia. Podrȩcznik dla studentów i lekarzy [Oncology: Handbook for students and physicians]. Medical Press, Gdańsk.
70. Rogounovitch T, Saenko V, Yamashita S, 2004. Mitochondrial DNA and human thyroid diseases. Endocr J 51: 265-277.
71. Rosson D, Keshgegian AA, 2004. Frequent mutations in the mitochondrial control region DNA in breast tissue. Cancer Lett 215: 89-94.
72. Savre-Train I, Piatyszek MA, Shay JW, 1992. Transcription of deleted mitochondrial DNA in human colon adenocarcinoma cells. Hum Mol Genet 1: 203-204.
73. Sharp MG, Adams SM, Walker RA, Brammar WJ, Varley JM, 1992. Differential expression of the mitochondrial gene cytochrome oxidase II in benign and malignant breast tissue. J Pathol 168: 163-168.
74. Shen H, Zhao M, Dong B, Tang W, Xiao B, Liu JZ, Lu YY, 2003. Frequent 4 977 bp deletion of mitochondrial DNA in tumor cell lines, solid tumors and precancerous lesions of human stomach. Zhonghua Yi Xue Za Zhi 83: 1484-1489.
75. Shi HH, Vincent L, Hextan N, Yang XY, 2002. Mutations in the D-loop region of mitochondrial DNA in ovarian tumors. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 24: 170-173.
76. Shidara Y, Yamagata K, Kanamori T, Nakano K, Kwong JQ, Manfredi G, et al. 2005. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res 65: 1655-1663.
77. Sidorik EP, Beregovskaia NN, 1983. Iron-sulfur centers and free radicals of the electron transfer chains of mitochondria in chemical and hormonal carcinogenesis. Ukr Biokhim Zh 55: 544-547.
78. Stempczyńska J, Potemski P, 2003 Nowotowory jajnika [Ovary neoplasms]. In: Kordek R, Jassem J, Krzakowski M, Jeziorski A, eds., Onkologia. Podrȩcznik dla studentów i lekarzy [Oncology: Handbook for students and physicians]. Medical Press, Gdańsk.
79. Takeuchi H, Fujimoto A, Hoon DS, 2004. Detection of mitochondrial DNA alterations in plasma of malignant melanoma patients. Ann N Y Acad Sci 1022: 50-54.
80. Tamori A, Nishiguchi S, Nishikawa M, Kubo S, Koh N, Hirohashi K, et al. 2004. Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma. J Gastroenterol 39: 1063-1068.
81. Tamura G, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Sakata K, et al. 1999. Mutations in mitochondrial control region DNA in gastric tumours of Japanese patients. Eur J Cancer 35: 316-319.
82. Tan DJ, Bai RK, Wong LJC, 2002. Comprehensive scanning of somatic mitochondrial DNA mutations in breast bancer. Cancer Res 62: 972-976.
83. Tenderenda M, 2003 Nowotwory żoła̧dka [Stomach neoplasms]. In: Kordek R, Jassem J, Krzakowski M, Jeziorski A, eds., Onkologia. Podrȩcznik dla studentów i lekarzy [Oncology: Handbook for students and physicians]. Medical Press, Gdańsk.
84. Vives-Bauza C, Gonzalo R, Manfredi G, Garcia-Arumi E, Andreu AL, 2006. Enhanced ROS production and antioxidant defenses in cybrids harbouring mutations in mtDNA. Neurosci Lett 391: 136-141.
85. Vogelstein B, Kinzler KW, 1993. The multistep nature of cancer. Trends Genet 9: 138-141.
86. Vonka V, Kanka J, Hirsch I, 1984. Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. II: herpes simplex type-2 antibody presence in sera taken at enrollment. Int J Cancer 33: 61-66.
87. Warburg O, 1956. On the Origin of Cancer Cells. Science 123: 309-314.
88. Wong LJC, Tan DJ, Bai RK, Yeh KT, Chang J, 2004. Molecular alterations in mitochondrial DNA of hepatocellular carcinomas: is there a correlation with clinicopathological profile? J Med Genet 41: e65.
89. Yamamoto A, Horai S, Yuasa Y, 1989. Increased level of mitochondrial gene expression in polyps of familial polyposis coli patients. Biochem Biophys Res Commun 159: 1100-1106.
90. Yeh JJ, Lunetta KL, van Orsouw NJ, Moore FD, Jr. Mutter GL, Vijg J, et al. 2000. Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours. Oncogene 19: 2060-2066.
91. Zhao YB, Yang HY, Zhang XW, Chen GY, 2005. Mutation in D-loop region of mitochondrial DNA in gastric cancer and its significance. World J Gastroenterol 11: 3304-3306.
92. Zhu W, Qin W, Bradley P, Wessel A, Puckett CL, Sauter ER, 2005. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid. Carcinog 26: 145-152.